Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
25.02
-0.28 (-1.11%)
At close: Aug 13, 2026, 4:00 PM EDT
25.10
+0.08 (0.32%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.49 billion as of August 13, 2026. Its market cap has increased by 164.88% in one year.
Market Cap
1.49B
Enterprise Value
1.14B
1-Year Change
164.88%
Ranking
Category
Stock Price
$25.02
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.49B, an increase of 128.08%. That is a compound annual growth rate of 18.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.49B | 6.41% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.56B |
| Maze Therapeutics | 1.54B |
| Vir Biotechnology | 1.52B |
| Jade Biosciences | 1.51B |
| Maravai LifeSciences Holdings | 1.50B |
| Innoviva | 1.50B |
| ArriVent BioPharma | 1.48B |
| LB Pharmaceuticals | 1.43B |